The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: First results of the endometrial sub-protocol following 2 years of treatment. - Duffy,S.R.; Jackson,T.L.; Landsdown,M. (Hum Reprod, 2006)